JAGX Stock Soars Over 10% Premarket After Best Day In Over 8 Years: What’s Driving The Surge?
Jaguar Health aims to file for approval of its Crofelemer powder treatment for pediatric MVID in mid-2027.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo